Prognostic restaging at the time of secondline therapy in patients with AL amyloidosis

Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis

12:30 EST 8 Feb 2019 | Nature Publishing

More From BioPortfolio on "Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis"